To Our New Jersey Life Sciences Community:
Welcome to another edition of The Weekender.
It’s Been a Banner Week for the New Jersey Life Sciences Community
At the State level, Biosimilars legislation (A2477) was approved by the Assembly in a unanimous vote (72-0). This legislation allows pharmacists to substitute biosimilar products as long as the conditions set forth in the bill are met. At the Federal level, an updated draft of the 21st Century Cures Act was advanced through the House Energy and Commerce Committee, Subcommittee on Health, marking an important step in delivering #Cures2015 to the President’s desk this year.
BioNJ Members Make FierceBiotech’s “25 Most Influential People in Biopharma” List
Congratulations to BioNJ Members Brent Saunders, Actavis; Bob Hugin, Celgene; David Epstein, Novartis; Serge Weinberg, Sanofi; and Flemming Ornskov, Shire for being placed on FierceBiotech’s list of the “25 Most Influential People in Biopharma.” This is a great accomplishment that makes New Jersey look good and BioNJ proud!
Click here for this week’s Weekender.